Sort by
Biochemistry, Genetics and Molecular Biology
Poly ADP Ribose Polymerase
100%
Adenosine Diphosphate
73%
Transferase
69%
Enzyme Active Site
49%
Epigallocatechin Gallate
39%
PARP1
39%
SARS Coronavirus
39%
AutoDock
34%
Enzyme
29%
Nicotinamide
28%
Adenine
28%
Quercetin
26%
Amination
26%
Prevalence
19%
Macrodomain
11%
Anticancer
10%
Cytokine Storm
9%
Proinflammatory Cytokine
9%
Virus
9%
Chemoluminescence
9%
Computer Simulation
9%
Interferon
9%
Antineoplastic Activity
8%
Naringenin
8%
Catechin
8%
Resveratrol
8%
Anti-Inflammatory
7%
Adenosine Diphosphate Ribose
6%
Diphtheria Toxin
6%
Double-Strand DNA Break
6%
Cancer Staging
6%
PKM2
6%
Binding Affinity
6%
Cancer Cell
6%
Metabolic Pathway
6%
Enzyme Activity
6%
Mammalian Target of Rapamycin
6%
Cell Growth
6%
Coronavirinae
6%
Protein Kinase B
6%
Luminescence
6%
Keyphrases
Poly(ADP-ribose) Polymerase
45%
ARTD8
29%
PARP14
29%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
26%
ADP-ribosyltransferase
19%
Natural Products
19%
COVID-19
19%
In Silico Identification
19%
In Vitro Activity
19%
Family Members
19%
Comorbidity
19%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
19%
Postdoctoral Research
19%
Novel Amines
19%
PARP-1 Inhibitors
19%
Cisplatin Efficacy
19%
Epigallocatechin Gallate
16%
Macrodomain
16%
Virtual Laboratory
9%
Bioscience
9%
Self-care Knowledge
9%
Educational Innovation
9%
Cancer Metastasis
9%
Understanding of Cancer
9%
Virus
9%
Self-care Skills
9%
Doctoral Studies
9%
Taubes
9%
Medicinal Chemistry
9%
Traditional Laboratory
9%
Biomedical Science
9%
General Practice
9%
Interferon Response
9%
Cytokine Storm
9%
Medical Research
9%
Primary Care
9%
Inflammatory Cytokines
9%
Practice nurse
9%
COPD Patients
9%
Personalized Education
9%
Teaching Fellows
9%
Australian Government
9%
Student Engagement
9%
PARP Inhibitors (PARPi)
8%
Complete Inhibition
8%
Indole-3-carbinol
8%
In Cancer
6%
Quercetin
6%
Viral
6%
Viral Replication
6%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
95%
Epigallocatechin Gallate
39%
Transferase
34%
Adenosine Diphosphate
34%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
32%
Enzyme
29%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
26%
Natural Product
25%
Prostate Cancer
22%
Lead Compound
20%
Carboxamide
19%
Cisplatin
19%
Inflammation
19%
Amine
19%
Adenine
13%
Nicotinamide
13%
Diseases
13%
Quercetin
11%
Androgen
9%
Prevalence
9%
Pathogenesis
9%
Phorbol 12,13-dibutyrate
8%
Protein Kinase B
7%
Adenosine Diphosphate Ribose
7%
Viability Assay
6%
Lethality
6%
Tumor Growth
6%
Cell Viability
6%
Survival Rate
6%
Drug Development
5%
Phytochemical
5%
